← FDA Drug Approvals (Drugs@FDA)

TOLVAPTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2025-04-23

Drug application

FDA Application #
ANDA216063
Application type
Abbreviated New Drug Application (Generic)
Brand name
TOLVAPTAN
Generic name
TOLVAPTAN
Active ingredients
TOLVAPTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
LUPIN
Manufacturer
Lupin Pharmaceuticals, Inc.
First approval
2025-04-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown